| Authors: |
Liu J; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: joyce_liu@dfci.harvard.edu., Burris H; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN, USA., Wang JS; Hematologic Oncology, Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, FL, USA., Barroilhet L; Department of Obstetrics and Gynecology, University of Wisconsin-Madison, Madison, WI, USA., Gutierrez M; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA., Wang Y; Early Clinical Development, Genentech, Inc, South San Francisco, CA, USA., Vaze A; Early Clinical Development, Genentech, Inc, South San Francisco, CA, USA., Commerford R; Early Clinical Development, Genentech, Inc, South San Francisco, CA, USA., Royer-Joo S; Early Clinical Development, Genentech, Inc, South San Francisco, CA, USA., Choeurng V; Early Clinical Development, Genentech, Inc, South San Francisco, CA, USA., Humke E; Early Clinical Development, Genentech, Inc, South San Francisco, CA, USA., Moore K; University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. |
